Abstract
(Int J Obstet Anesth. 2022;52:103592) Neuraxial anesthesia is the analgesia of choice during cesarean delivery which frequently includes long‐acting morphine. While the standard practice, neuraxial morphine poses an increased risk of delayed respiratory depression. While the risk is low at 1.08 to 1.63 per 10,000 cases, patient comorbidities can increase occurrence. In 2019, the Society for Obstetric Anesthesia and Perinatology (SOAP) gave guidelines for patient surveillance following cesarean delivery (CD) with morphine though evidence-based research is lacking and is rather a result of expert opinion. The aim of this retrospective study was to determine the occurrence of respiratory depression in CD patients who received neuraxial morphine for pain management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
